Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?
Wolfgang Korte1,21Center for Laboratory Medicine, 2Center for Hemostaseology and Hemophilia, St Gallen, SwitzerlandAbstract: Circulating factor XIII (FXIII) consists of two active (A) and two carrier (B) subunits in tetrameric form. Congenital FXIII deficiency is a rare autosomal-recessive trait tha...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-07-01
|
| Series: | Journal of Blood Medicine |
| Online Access: | http://www.dovepress.com/catridecacog-a-breakthrough-in-the-treatment-of-congenital-factor-xiii-a17529 |